MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma

American Journal of Cancer Research

Volumn 4, Issue 6, 2014, Pages 897-906

  Yu, Lei ^a   Zhou, Luting ^b   Cheng, Yu ^a   Sun, Lei ^c   Fan, Jian ^a   Liang, Jinlong ^d   Guo, Mujie ^e   Liu, Ning ^e   Zhu, Liying ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b JINAN MILITARY GENERAL HOSPITAL   (China)

^c Medical University   (China)

^d Heilongjiang Province Hospital   (China)

^e JINING MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; miR 543; Oncogene; PAQR3

Indexed keywords

MICRORNA; MICRORNA 543; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DEREGULATION; FEMALE; GENE; GENE TARGETING; HEPG2 CELL LINE; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PAQR3 GENE; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 84937871541     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Caffarelli E and Filetici P. Epigenetic regulation in cancer development. Front Biosci (Landmark Ed) 2011; 16: 2682-2694.
2. Rosell R, Cuello M, Cecere F, Santarpia M, Reguart N, Felip E and Taron M. Usefulness of predictive tests for cancer treatment. Bull Cancer 2006; 93: E101-108.
3. Wang PR, Xu M, Toffanin S, Li Y, Llovet JM and Russell DW. Induction of hepatocellular carcinoma by in vivo gene targeting. Proc Natl Acad Sci U S A 2012; 109: 11264-11269.
4. Zucman-Rossi J. Molecular classification of hepatocellular carcinoma. Dig Liver Dis 2010; 42 Suppl 3: S235-241.
5. Banaudha KK and Verma M. The role of microRNAs in the management of liver cancer. Methods Mol Biol 2012; 863: 241-251.
6. Fornari F, Milazzo M, Chieco P, Negrini M, Marasco E, Capranico G, Mantovani V, Marinello J, Sabbioni S, Callegari E, Cescon M, Ravaioli M, Croce CM, Bolondi L and Gramantieri L. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J Pathol 2012; 227: 275-285.
7. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I and Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31: 766-776.
8. Liu Y, Zhang JB, Qin Y, Wang W, Wei L, Teng Y, Guo L, Zhang B, Lin Z, Liu J, Ren ZG, Ye QH and Xie Y. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1alpha expression and protein stability. Hepatology 2013; 58: 692-705.
9. Yu X, Li Z, Shen J, Wu WK, Liang J, Weng X and Qiu G. MicroRNA-10b Promotes Nucleus Pulposus Cell Proliferation through RhoC-Akt Pathway by Targeting HOXD10 in Intervetebral Disc Degeneration. PLoS One 2013; 8: e83080.
10. He W, Li Y, Chen X, Lu L, Tang B, Wang Z, Pan Y, Cai S, He Y and Ke Z. miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc. J Gastroenterol Hepatol 2014; 29: 1427-34.
11. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES and Zhang C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009; 105: 158-166.
12. Gong M, Ma J, Guillemette R, Zhou M, Yang Y, Hock JM and Yu X. MiR-335 Inhibits Small Cell Lung Cancer Bone Metastases via IGF-IR and RANKL Pathways. Mol Cancer Res 2014; 12: 101-110.
13. Jung CJ, Iyengar S, Blahnik KR, Ajuha TP, Jiang JX, Farnham PJ and Zern M. Epigenetic modulation of miR-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferation. PLoS One 2011; 6: e27740.
14. Jin J, Cai L, Liu ZM and Zhou XS. miRNA-218 Inhibits Osteosarcoma Cell Migration and Invasion by Down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev 2013; 14: 3681-3684.
15. Jin Y, Peng D, Shen Y, Xu M, Liang Y, Xiao B and Lu J. MicroRNA-376c inhibits cell proliferation and invasion in osteosarcoma by targeting to transforming growth factor-alpha. DNA Cell Biol 2013; 32: 302-309.
16. Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C, Gronbaek K, Federspiel B, Lund AH and Friis-Hansen L. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 2011; 10: 29.
17. Chan SH, Wu CW, Li AF, Chi CW and Lin WC. miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 2008; 28: 907-911.
18. Cho WJ, Shin JM, Kim JS, Lee MR, Hong KS, Lee JH, Koo KH, Park JW and Kim KS. miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. Mol Cells 2009; 28: 521-527.
19. Furuta M, Kozaki K, Tanimoto K, Tanaka S, Arii S, Shimamura T, Niida A, Miyano S and Inazawa J. The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma. PLoS One 2013; 8: e60155.
20. Lang Q and Ling C. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. Biochem Biophys Res Commun 2012; 426: 247-252.
21. Li L, Guo Z, Wang J, Mao Y and Gao Q. Serum miR-18a: A Potential Marker for Hepatitis B Virus-Related Hepatocellular Carcinoma Screening. Dig Dis Sci 2012; 57: 2910-2916.
22. Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY and Zhu ZG. MiRNA-199a-3p in Plasma as a Potential Diagnostic Biomarker for Gastric Cancer. Ann Surg Oncol 2013; 3: S397-405.
23. He C, Xiong J, Xu X, Lu W, Liu L, Xiao D and Wang D. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples. Biochem Biophys Res Commun 2009; 388: 35-40.
24. Gu H, Yang T, Fu S, Chen X, Guo L and Ni Y. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1. Biochem Biophys Res Commun 2014; 444: 104-108.
25. Du B, Wang Z, Zhang X, Feng S, Wang G, He J and Zhang B. MicroRNA-545 Suppresses Cell Proliferation by Targeting Cyclin D1 and CDK4 in Lung Cancer Cells. PLoS One 2014; 9: e88022.
26. Fei X, Qi M, Wu B, Song Y, Wang Y and Li T. MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression. FEBS Lett 2012; 586: 392-397.
27. Bing L, Hong C, Li-Xin S and Wei G. MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression. Arch Gynecol Obstet 2014; 3: 533-41.
28. Haga CL and Phinney DG. MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network. J Biol Chem 2012; 287: 42695-42707.
29. Garitaonandia I, Smith JL, Kupchak BR and Lyons TJ. Adiponectin identified as an agonist for PAQR3/RKTG using a yeast-based assay system. J Recept Signal Transduct Res 2009; 29: 67-73.
30. Wang X, Wang L, Zhu L, Pan Y, Xiao F, Liu W, Wang Z, Guo F, Liu Y, Thomas WG and Chen Y. PAQR3 modulates insulin signaling by shunting phosphoinositide 3-kinase p110alpha to the Golgi apparatus. Diabetes 2013; 62: 444-456.
31. Wang L, Wang X, Li Z, Xia T, Zhu L, Liu B, Zhang Y, Xiao F, Pan Y, Liu Y, Guo F and Chen Y. PAQR3 has modulatory roles in obesity, energy metabolism, and leptin signaling. Endocrinology 2013; 154: 4525-4535.
32. Wang X, Li X, Fan F, Jiao S, Wang L, Zhu L, Pan Y, Wu G, Ling ZQ, Fang J and Chen Y. PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers. Carcinogenesis 2012; 33: 2228-2235.
33. Zhang Y, Jiang X, Qin X, Ye D, Yi Z, Liu M, Bai O, Liu W, Xie X, Wang Z, Fang J and Chen Y. RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma. Oncogene 2010; 29: 5404-5415.
34. Ling ZQ, Guo W, Lu XX, Zhu X, Hong LL, Wang Z and Chen Y. A Golgi-specific protein PAQR3 is closely associated with the progression, metastasis and prognosis of human gastric cancers. Ann Oncol 2014; 25: 1363-1372.